EntryPoint Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$505K Sell
2025
Q1
$638K Sell
2024
Q4
$598K Buy
2024
Q3
$438K Buy
2024
Q2
Sell
2024
Q1
$258K Buy
2023
Q4
$194K Buy